![]() |
Name |
rhizovarin A
|
Molecular Formula | C37H44ClNO8 | |
IUPAC Name* |
26-chloro-2,3,19,19-tetramethyl-23-methylidene-12-prop-1-en-2-yl-8,13,18,20-tetraoxa-33-azadecacyclo[27.3.1.02,27.03,24.06,17.07,9.07,14.017,23.021,32.022,30]tritriaconta-1(32),24,26,29-tetraene-6,11,17,21,30-pentol
|
|
SMILES |
C=C(C)C1OC2CCC3(C)C(O)(CCC4(O)OC5OC(C)(C)C6CC7C(=C)Cc8c(Cl)cc9[nH]c(c5c9c8C76O)C43C)C23OC3C1O
|
|
InChI |
InChI=1S/C37H44ClNO8/c1-15(2)27-26(40)29-37(45-29)22(44-27)8-9-32(6)33(7)28-24-23-20(39-28)14-19(38)17-12-16(3)18-13-21(36(18,43)25(17)23)31(4,5)46-30(24)47-35(33,42)11-10-34(32,37)41/h14,18,21-22,26-27,29-30,39-43H,1,3,8-13H2,2,4-7H3/t18-,21-,22+,26+,27-,29-,30+,32-,33-,34+,35+,36-,37+/m1/s1
|
|
InChIKey |
XQIBLEBIZKYRNS-KAMINZTDSA-N
|
|
Synonyms |
NA
|
|
CAS | NA | |
PubChem CID | NA | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 666.21 | ALogp: | 4.7 |
HBD: | 5 | HBA: | 8 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 136.9 | Aromatic Rings: | 10 |
Heavy Atoms: | 47 | QED Weighted: | 0.209 |
Caco-2 Permeability: | -5.172 | MDCK Permeability: | 0.00001240 |
Pgp-inhibitor: | 0.884 | Pgp-substrate: | 0.068 |
Human Intestinal Absorption (HIA): | 0.808 | 20% Bioavailability (F20%): | 0.639 |
30% Bioavailability (F30%): | 0.187 |
Blood-Brain-Barrier Penetration (BBB): | 0.994 | Plasma Protein Binding (PPB): | 88.63% |
Volume Distribution (VD): | 1.951 | Fu: | 2.74% |
CYP1A2-inhibitor: | 0.005 | CYP1A2-substrate: | 0.987 |
CYP2C19-inhibitor: | 0.038 | CYP2C19-substrate: | 0.78 |
CYP2C9-inhibitor: | 0.111 | CYP2C9-substrate: | 0.087 |
CYP2D6-inhibitor: | 0.005 | CYP2D6-substrate: | 0.356 |
CYP3A4-inhibitor: | 0.504 | CYP3A4-substrate: | 0.916 |
Clearance (CL): | 7.919 | Half-life (T1/2): | 0.002 |
hERG Blockers: | 0.552 | Human Hepatotoxicity (H-HT): | 0.312 |
Drug-inuced Liver Injury (DILI): | 0.456 | AMES Toxicity: | 0.036 |
Rat Oral Acute Toxicity: | 0.999 | Maximum Recommended Daily Dose: | 0.956 |
Skin Sensitization: | 0.075 | Carcinogencity: | 0.958 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.984 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC001891 | ![]() |
0.769 | D0KR9U | ![]() |
0.219 | ||
ENC003830 | ![]() |
0.704 | D0W2EK | ![]() |
0.212 | ||
ENC001508 | ![]() |
0.641 | D0S0NK | ![]() |
0.212 | ||
ENC001507 | ![]() |
0.599 | D06IIB | ![]() |
0.210 | ||
ENC003831 | ![]() |
0.586 | D0Y2YP | ![]() |
0.203 | ||
ENC001499 | ![]() |
0.509 | D0M2QH | ![]() |
0.197 | ||
ENC003453 | ![]() |
0.450 | D03MTN | ![]() |
0.196 | ||
ENC001486 | ![]() |
0.382 | D0AR3J | ![]() |
0.193 | ||
ENC003833 | ![]() |
0.368 | D02JNM | ![]() |
0.192 | ||
ENC003787 | ![]() |
0.360 | D06AEO | ![]() |
0.190 |